Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 103.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 25,020
  • Market Cap: £87.22m
  • RiskGrade: 196

Dividend Data

  31-Dec-2231-Dec-2131-Dec-2031-Dec-1931-Dec-18
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Continuing Operations          
Revenue 19.50 13.94 12.70 13.44 10.37
Operating Profit/(Loss) 0.57 0.55 (0.66) (0.74) 1.20
Net Interest (0.01) (0.09) (0.02) (0.24) (0.32)
Profit Before Tax 0.56 0.46 (0.68) 0.50 0.88
Profit After Tax 0.72 0.56 0.26 0.40 0.63
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 0.72 0.56 0.26 0.40 0.63
Attributable to:          
Equity Holders of Parent Company 0.72 0.56 0.26 0.40 0.63
Minority Interests n/a n/a n/a n/a n/a
           
Continuing EPS          
Earnings per Share - Basic 0.86p 0.67p 0.34p 0.62p 1.41p
Earnings per Share - Diluted 0.84p 0.66p 0.34p 0.62p 1.41p
Earnings per Share - Adjusted 0.86p 0.67p 0.74p 2.46p 1.86p
Continuing and Discontinued EPS          
Earnings per Share - Basic 0.86p 0.67p 0.34p 0.62p 1.41p
Earnings per Share - Diluted 0.84p 0.66p 0.34p 0.62p 1.41p
Earnings per Share - Adjusted 0.86p 0.67p 0.74p 2.46p 1.86p
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Assets          
Non-Current Assets          
Property, Plant & Equipment 2.09 2.13 0.24 0.13 0.07
Intangible Assets 15.22 12.82 9.36 3.76 1.21
Investment Properties n/a n/a n/a n/a n/a
Investments n/a n/a n/a n/a n/a
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 0.05 n/a 0.30 0.06 0.06
  17.36 14.95 9.90 3.95 1.35
Current Assets          
Inventories n/a n/a n/a n/a n/a
Trade & Other Receivables 11.06 10.39 6.11 6.64 4.39
Cash at Bank & in Hand 19.84 19.67 25.25 11.72 2.07
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets n/a n/a 2.26 0.07 n/a
  30.90 30.06 33.62 18.42 6.46
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 48.26 45.01 43.52 22.37 7.81
           
Liabilities          
Current Liabilities          
Borrowings 0.12 0.28 0.12 0.11 2.72
Other Current Liabilities 3.63 2.36 2.80 2.13 1.22
  3.75 2.63 2.91 2.24 3.93
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 1.21 1.28 n/a n/a 1.07
Provisions 0.79 0.44 0.37 n/a n/a
Other Non-Current Liabilities n/a n/a n/a n/a 0.18
  1.99 1.73 0.37 n/a 1.25
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 5.74 4.36 3.28 2.24 5.18
           
Net Assets 42.51 40.65 40.24 20.13 2.63
           
Capital & Reserves          
Share Capital 0.17 0.17 0.17 0.14 n/a
Share Premium Account 37.13 36.86 36.86 17.33 0.10
Other Reserves (0.12) (0.47) 0.01 0.02 0.29
Retained Earnings 5.34 4.08 3.19 2.64 2.24
Shareholders Funds 42.51 40.65 40.24 20.13 2.63
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 42.51 40.65 40.24 20.13 2.63
Cash Flow 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Net Cash Flow From Operating Activities 5.10 0.57 0.25 (0.63) (0.95)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (4.76) (5.60) (6.29) (2.92) (1.11)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (0.19) (0.27) 19.61 13.29 1.05
Net Increase/Decrease In Cash 0.15 (5.30) 13.57 9.74 (1.01)
Ratios - based on IFRS 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Continuing Operations          
PE Ratio - Adjusted 87.8 152.2 180.4 41.5 n/a
PEG - Adjusted 3.1 n/a n/a 1.3 n/a
Earnings per Share Growth - Adjusted 28% -10% -70% 32% n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 23.03p 0.17p 15.00p 15.87p 12.25p
Pre-Tax Profit per Share 0.67p 0.006p (0.80p) 0.59p 1.04p
Operating Margin 2.95% 3.94% (5.20%) (5.51%) 11.58%
Return on Capital Employed 1.96% 0.02% n/a 4.49% 23.09%
Continuing & Discontinued Operations          
PE Ratio - Adjusted 87.8 15,082.1 180.4 41.5 n/a
PEG - Adjusted 0.0 n/a n/a 1.3 n/a
Earnings per Share Growth - Adjusted 12,616% -99% -70% 32% n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 6.02p 0.67p 0.30p (0.74p) n/a
Cash Incr/Decr per Share 0.17p (0.063p) 16.03p 11.50p (1.20p)
Net Asset Value per Share (exc. Intangibles) 32.23p 32.86p 36.46p 19.33p 1.68p
Net Gearing -43.54% -44.56% -62.47% -57.68% 64.94%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page